WSH

Long Grove Pharmaceuticals

Building on the success of our companies specializing in generic drug reformulation, Water Street launched Long Grove Pharmaceuticals in 2019. Long Grove stands out for its strength in addressing generic development opportunities with complex formulations, challenging manufacturing and supply chain dynamics, and unique regulatory approval pathways in niche markets. Long Grove both develops complex generic products for its own portfolio and partners with healthcare organizations to create new entities that lead development and regulatory approval of products on their behalf. Al Heller, a Water Street operating partner who has more than 35 years of leadership experience in life sciences, serves as the company’s chairman. He and the leadership team are actively pursuing a robust pipeline of partnership and product development opportunities.

Subscribe to Water Street News

To receive Water Street news via email,
please complete the form below.

Privacy Policy

You’ve just been sent an email to confirm your email address. Please click on the link in the email to activate your subscription.

If you do not receive an email from us within a few minutes, please check your spam folder. If our email did not come through to you, please click on this link, news@waterstreet.com